4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-009405
EVP & Chief Financial Officer gave up 4,819 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MCGRATH JOHN EVP & Chief Financial Officer | 2018-02-09 | Shares withheld for taxes | −4,819 | $41.70 | $200,952 | 105,556 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…